This review summarizes the evidence for the management of sarcopenia in patients with
rheumatoid arthritis (RA) in terms of drugs, exercise, and nutrition. Sarcopenia is a decrease in …

Background Effects of antihyperglycemic therapies on cardiovascular and heart failure (HF)
risks have varied widely across cardiovascular outcome trials (CVOTs), and underlying …

Aim To evaluate the cardiovascular and renal outcomes of glucagon‐like peptide‐1 receptor
agonists (GLP‐1 RAs) and the associations between these outcomes and HbA1c or weight …

Sarcopenia is an age-related disease with an increased risk of mortality. It is emerging that
low serum 25-hydroxyvitamin D [25(OH)D] affects the sarcopenic state in general, but in …

Objective To clarify the relationship among serum adiponectin, body composition, current
disease activity and therapeutics of rheumatoid arthritis (RA). Methods We conducted a cross-…

Aims Sodium‐glucose co‐transporter 2 (SGLT2) inhibitors reduce the risk of heart failure (HF)
events regardless of diabetes status. However, factors associated with their efficacy in HF …

Frailty is a geriatric syndrome characterized by anabolic-catabolic imbalance and multisystem
dysregulation resulting in increased adverse health outcomes, and is closely related with …

Background Excessive salt intake is thought to exacerbate both development of hypertension
and autoimmune diseases in animal models, but the clinical impact of excessive salt in …

Objectives We aimed to determine the clinical impact of plasma homocysteine levels on disease
activity and clinical remission in patients with rheumatoid arthritis (RA). Methods A cross-…

The high thermogenic activity of brown adipose tissue (BAT) has received considerable
attention. Here, we demonstrated the role of the mevalonate (MVA) biosynthesis pathway in the …